Skip to main content

Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)

Completed · Phase 3 · NCT04542499

Conditions: Parkinson Disease

At a glance

Research payments reported, 2025
$116,945
U.S. investigators named
16
Sites paid
17
Planned or actual enrollment
507

About the trial

Sponsor
AbbVie
Tested
Tavapadon (drug), Placebo (drug)
Dates
Started 2020-09-23; completion 2024-02-15
Results posted
Yes

The purpose of this study is to assess the effect of tavapadon on the change from baseline in total daily hours of "on" time without troublesome dyskinesia in L-Dopa-treated participants with Parkinson's Disease (PD) who are experiencing motor fluctuations.

From ClinicalTrials.gov, last updated 2025-04-04. Full record, eligibility and contacts (opens in a new tab)

Industry funding

AbbVie Inc. reported $116,945 in research payments for this study in 2025 (28 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Healthcare Innovations Institute LLC $31,007
  • Central Texas Neurology Consultants $21,605
  • Denver Neurological Research LLC $10,000
  • Roseman Medical Research Institute LLC $9,000
  • Neuro-Pain Medical Center Inc $8,565
  • Virginia Commonwealth University $7,946
  • Cleveland Clinic, OH $7,298
  • Baylor College of Medicine $6,762
  • $2,870
  • Neurology Associates PA $2,344
  • Interspond LLC $2,248
  • University of Texas Health Science Center at Houston $1,745
  • Horizon Solutions Inc $1,527
  • Henrico Doctors Neurology Associates LLC $1,298
  • Henry Ford Health Hospital, MI $1,154
  • Rush University Medical Center, IL $977
  • Parkinsons and Movement Disorder Institute $550
  • The University of South Florida Board of Trustees $50

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.